BRISTOL MYERS SQUIBB CO Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Bristol Myers Squibb Co quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2010 to Q3 2024.
  • Bristol Myers Squibb Co Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $1.21B, a 37.2% decline year-over-year.
  • Bristol Myers Squibb Co Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$7.26B, a 188% decline year-over-year.
  • Bristol Myers Squibb Co annual Net Income (Loss) Attributable to Parent for 2023 was $8.03B, a 26.8% increase from 2022.
  • Bristol Myers Squibb Co annual Net Income (Loss) Attributable to Parent for 2022 was $6.33B, a 9.54% decline from 2021.
  • Bristol Myers Squibb Co annual Net Income (Loss) Attributable to Parent for 2021 was $6.99B.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$7.26B $1.21B -$717M -37.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 -$6.54B $1.68B -$393M -19% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-26
Q1 2024 -$6.15B -$11.9B -$14.2B -627% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $8.03B $1.76B -$260M -12.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-13
Q3 2023 $8.29B $1.93B +$322M +20.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $7.96B $2.07B +$652M +45.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-26
Q1 2023 $7.31B $2.26B +$984M +77% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 $6.33B $2.02B -$350M -14.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-13
Q3 2022 $6.68B $1.61B +$60M +3.88% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 $6.62B $1.42B +$366M +34.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-27
Q1 2022 $6.25B $1.28B -$743M -36.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-27
Q4 2021 $6.99B $2.37B +$12.4B Oct 1, 2021 Dec 31, 2021 10-K 2024-02-13
Q3 2021 -$5.41B $1.55B -$326M -17.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-26
Q2 2021 -$5.08B $1.06B +$1.14B Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-27
Q1 2021 -$6.22B $2.02B +$2.8B Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 -$9.02B -$10B -$8.97B -850% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-10
Q3 2020 -$44M $1.87B +$519M +38.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-27
Q2 2020 -$563M -$85M -$1.52B -106% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-28
Q1 2020 $954M -$775M -$2.49B -145% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 $3.44B -$1.06B -$2.22B -191% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-10
Q3 2019 $5.66B $1.35B -$548M -28.8% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-10
Q2 2019 $6.2B $1.43B +$1.06B +284% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-10
Q1 2019 $5.14B $1.71B +$224M +15.1% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-10
Q4 2018 $4.92B $1.16B +$3.49B Oct 1, 2018 Dec 31, 2018 10-K 2020-02-24
Q3 2018 $1.43B $1.9B +$1.06B +125% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-24
Q2 2018 $376M $373M -$543M -59.3% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-24
Q1 2018 $919M $1.49B -$88M -5.59% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-24
Q4 2017 $1.01B -$2.33B -$3.22B -360% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-25
Q3 2017 $4.23B $845M -$357M -29.7% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-25
Q2 2017 $4.59B $916M -$250M -21.4% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-25
Q1 2017 $4.84B $1.57B +$379M +31.7% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-25
Q4 2016 $4.46B $894M +$1.09B Oct 1, 2016 Dec 31, 2016 10-K 2018-02-13
Q3 2016 $3.37B $1.2B +$496M +70.3% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-13
Q2 2016 $2.87B $1.17B +$1.3B Apr 1, 2016 Jun 30, 2016 10-K 2018-02-13
Q1 2016 $1.57B $1.2B +$9M +0.76% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-13
Q4 2015 $1.57B -$197M -$210M -1615% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-21
Q3 2015 $1.78B $706M -$15M -2.08% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-21
Q2 2015 $1.79B -$130M -$463M -139% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-21
Q1 2015 $2.25B $1.19B +$249M +26.6% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-21
Q4 2014 $2B $13M -$713M -98.2% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-12
Q3 2014 $2.72B $721M +$29M +4.19% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-12
Q2 2014 $2.69B $333M -$203M -37.9% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-12
Q1 2014 $2.89B $937M +$328M +53.9% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-12
Q4 2013 $2.56B $726M -$199M -21.5% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-13
Q3 2013 $2.76B $692M +$1.4B Jul 1, 2013 Sep 30, 2013 10-K 2015-02-13
Q2 2013 $1.36B $536M -$109M -16.9% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-13
Q1 2013 $1.47B $609M -$492M -44.7% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-13
Q4 2012 $1.96B $925M +$73M +8.57% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-14
Q3 2012 $1.89B -$711M -$1.68B -173% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-14
Q2 2012 $3.57B $645M -$257M -28.5% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-14
Q1 2012 $3.82B $1.1B +$115M +11.7% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-14
Q4 2011 $3.71B $852M +$369M +76.4% Oct 1, 2011 Dec 31, 2011 10-K 2013-02-15
Q3 2011 $3.34B $969M +$20M +2.11% Jul 1, 2011 Sep 30, 2011 10-K 2013-02-15
Q2 2011 $3.32B $902M -$25M -2.7% Apr 1, 2011 Jun 30, 2011 10-K 2013-02-15
Q1 2011 $3.35B $986M +$243M +32.7% Jan 1, 2011 Mar 31, 2011 10-K 2013-02-15
Q4 2010 $3.1B $483M Oct 1, 2010 Dec 31, 2010 10-K 2011-02-18
Q3 2010 $949M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-27
Q2 2010 $927M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-28
Q1 2010 $743M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.